banner
p38-MAPK inhibitor Dilmapimod, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ911

p38-MAPK inhibitor Dilmapimod, Purity ≥98%

Synonym: Dilmapimod; 444606-18-2; SB-681323; Dilmapimod [USAN:INN]; GW 681323; UNII-Q3238VQW0N; Q3238VQW0N; p38-MAPK inhibitor

  • CAS Number: 444606-18-2
  • Compound CID: 10297982
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Dilmapimod targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates.
Molecular Weight
456.42
Molecular Formula
C23H19F3N4O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Dilmapimod serves as a research tool to assess the inhibition of p38 MAP kinase for therapeutic potentials in chronic obstructive pulmonary disease (COPD) and other inflammatory conditions.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0